Breast Imaging

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast tomosynthesis (DBT) dataset with paired histology outcomes.

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual tumor marker designed to provide artifact-free visibility across all major breast imaging modalities, including MRI, mammography, X-ray, CT and ultrasound.

Jan. 14, 2026 — Susan G.

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D quantitative breast ultrasound platform. Designed to bring high-quality imaging into everyday clinics, ATUSA unlocks the $14B U.S.

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than annual mammograms, can lower the chance of more advanced cancers, while still safely match people to the amount of screening they need.